PeptidePedia The community reference

Adverse effects of GLP-1 receptor agonists: difference between revisions

Diff·revision 43 → 44·08:50, 12 Jul 2026

Difference between revision 43 and revision 44 of Adverse effects of GLP-1 receptor agonists. This revision changed no lines of source — the edit was a null or whitespace change.

Revision 43 — 08:50, 21 Jun 2026
AppendixAlva (talk)
add the discontinuation rate attributable to this effect
5,791 bytes ±0
Revision 44 — 08:50, 12 Jul 2026
LeanMassLars (talk)
give the incidence with its denominator
5,791 bytes ±0
No change to the page source.